Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Film-coated tablet: 30 mg, 60 mg
Registered products in the Philippines
3 products registered with the Food and Drug Administration (FDA) Philippines list Daclastavir as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products3
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Dacihep 30Daclastavir (As dihydrochloride) | 30 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's); Box of 10's | Rx | Cadila Healthcare LimitedIndia | Zydus Healthcare Philippines, Inc. | DR-XY47856 | Mar 31, 2027 | |
Dacihep 30Daclastavir Dihydrochloride | 30 mg Film Coated Tablet28 tablets in HDPE Bottle | Rx | Cadila Healthcare LimitedIndia | Zydus Healthcare Philippines, Inc. | DR-XY47857 | Mar 31, 2027 | |
Dacihep 60Daclastavir (As dihydrochloride) | 60 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's); Box of 10's as Physician's Sample | Rx | Cadila Healthcare LimitedIndia | Zydus Healthcare Philippines, Inc. | DR-XY47858 | Mar 31, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .